Economic Evaluation of Omalizumab Compared With Standard Therapy in the Treatment of Severe Allergic Asthma in Adult Patients in Greece: a Cost Effectiveness Analysis Based on Clinical Trial and Real-World Data.
| Autor: | Sonathi V; Novartis Healthcare Pvt. Ltd., Hyderabad, India., Hatzikou M; Novartis Hellas, Metamorfosis, Greece., Baldwin M; Novartis Employee by the time of the study, Horsham, UK., Panitti E; Novartis Hellas, Metamorfosis, Greece., Tzortzaki E; Medical School University of Crete, Heraklion, Greece. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2014 Nov; Vol. 17 (7), pp. A597-8. Date of Electronic Publication: 2014 Oct 26. |
| DOI: | 10.1016/j.jval.2014.08.2065 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect